top of page
Blue Background

Pipeline

Technology 

Mechanism(s)

Indication 

Discovery

Preclinical

Phase I

Masked ImmunoCytokine 

CD138+ Solid Tumors

Multiple Myeloma

CD138 targeted IFNα2

Nammisome

ICD Inducing Chemotherapeutic

Solid Tumors

Nammisome

ICD Inducing Chemotherapeutic+

TLR7 Agonist 

Solid Tumors

NTI-XXX

Masked ImmunoCytokine 

TBD

Solid Tumor

bottom of page